Insider Transactions Reported by 25 Insiders of Aquestive Therapeutics, Inc.

Symbol
AQST on Nasdaq
Location
Warren, NJ

Insiders trading volume in the past year

Aquestive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander Mark Schobel Chief Innovation/Tech Officer $5,906,856 15 Mar 2024
Daniel Barber President and CEO, Director $5,572,253 -$553,591 -9% 26 Sep 2025
Carl N. Kraus Chief Medical Officer $1,977,325 -$141,904 -6.7% 15 Oct 2025
Peter E. Boyd Chief People Officer $1,767,419 -$212,500 -11% 04 Dec 2025
Cassie Jung Chief Operating Officer $1,698,984 -$784,601 -32% 15 Oct 2025
Melina Cioffi SVP, Regulatory Affairs $1,187,055 02 Dec 2025
LORI J. BRAENDER Chief Legal Officer $1,067,900 07 Mar 2025
Douglas K. Bratton 10%+ Owner $1,033,452 02 Dec 2024
A. ERNEST TOTH JR Chief Financial Officer $899,320 07 Mar 2025
Stephen Wargacki Chief Science Officer $872,622 07 Mar 2025
Sherry Korczynski Chief Commercial Officer $700,153 14 Aug 2025
Keith J. Kendall CEO and President, Director $516,091 10 Mar 2022
John Cochran Director $441,678 11 Jun 2025
GREGORY B. BROWN Director $368,475 11 Jun 2025
Matthew W. Davis Chief Development Officer $279,500 10 Nov 2025
Marco Taglietti Director $143,220 11 Jun 2025
Julie Krop Director $143,220 11 Jun 2025
TIMOTHY E. MORRIS Director $143,220 11 Jun 2025
Abigail L. Jenkins Director $143,220 11 Jun 2025
Ken W. Marshall SVP, Chief Commercial Officer $122,670 09 Aug 2023
SANTO J. COSTA Director $103,962 20 Jun 2024
James S. Scibetta Director $25,624 15 Jun 2021
Kenneth Truitt Chief Medical Officer 06 Sep 2022
Nancy Lurker Director 15 Jun 2021
Theresa Wood SVP-HR and Org. Development 10 Mar 2022

Recent Insider Transactions by Companies or Individuals for Aquestive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.